Represented¹ | Represented¹ | ||||||
Pre- | Exceptional | Pre- | Exceptional | ||||
exceptional | items | exceptional | items | Represented¹ | |||
items | (note 4) | Total | items | (note 4) | Total | ||
2024 | 2024 | 2024 | 2023 | 2023 | 2023 | ||
Note | £m | £m | £m | £m | £m | £m | |
Revenue | 3 | ||||||
Cost of sales | ( | ( | ( | ( | ( | ( | |
Gross profit/(loss) | ( | ( | ( | ||||
Other operating income | 5 | ||||||
Other operating expenses | 5 | ( | ( | ( | ( | ||
Administrative expenses | ( | ( | ( | ( | ( | ||
Net impairment losses on financial assets | 17 | ( | ( | ( | ( | ||
Operating profit/(loss) | 5 | ( | ( | ( | |||
Finance income | 7 | ||||||
Finance expense | 7 | ( | ( | ( | ( | ( | ( |
Net finance expense | ( | ( | ( | ( | ( | ( | |
Share of post-tax (losses)/profits of joint ventures using the equity method | 14 | ( | ( | ||||
Profit/(loss) before tax | ( | ( | ( | ||||
Income tax (expense)/credit | 8 | ( | ( | ( | |||
Profit/(loss) for the year attributable to equity shareholders | ( | ( | ( | ||||
Earnings/(loss) per ordinary share | |||||||
Basic | 10 | ( | |||||
Diluted | 10 | ( |
2024 | 2023 | ||
Note | £m | £m | |
(Loss)/profit for the year attributable to equity shareholders | ( | ||
Other comprehensive income/(expense): | |||
Items that will not be reclassified to the consolidated income statement: | |||
Actuarial gains/(losses) of defined benefit schemes | 16 | ( | |
Change in deferred tax on actuarial gains/(losses) of defined benefit schemes | 15 | ( | |
Other comprehensive income/(expense) for the year net of income tax | ( | ||
Total comprehensive (expense)/income attributable to equity shareholders | ( |
Share | |||||
Share | premium | Retained | |||
capital | account | earnings | Total equity | ||
Note | £m | £m | £m | £m | |
Balance at 1 November 2022 | |||||
Profit for the year attributable to equity shareholders | |||||
Actuarial losses of defined benefit schemes | 16 | ( | ( | ||
Change in deferred tax on actuarial losses of defined benefit schemes | 15 | ||||
Total comprehensive income for the year | |||||
Transactions with shareholders: | |||||
Equity-settled share-based payments | 16 | ||||
Deferred tax on equity-settled share-based payments | 15 | ( | ( | ||
Purchase of own shares | 23 | ( | ( | ||
Transfers in respect of share options | |||||
Dividends paid | 9 | ( | ( | ||
Balance at 31 October 2023 | |||||
Loss for the year attributable to equity shareholders | ( | ( | |||
Actuarial gains of defined benefit schemes | 16 | ||||
Change in deferred tax on actuarial gains of defined benefit schemes | 15 | ( | ( | ||
Total comprehensive expense for the year | ( | ( | |||
Transactions with shareholders: | |||||
Equity-settled share-based payments | 16 | ||||
Deferred tax on equity-settled share-based payments | 15 | ||||
Purchase of own shares | 23 | ( | ( | ||
Transfers in respect of share options | |||||
Dividends paid | 9 | ( | ( | ||
Balance at 31 October 2024 |
Represented 1 | |||
2024 | 2023 | ||
Note | £m | £m | |
ASSETS | |||
Non-current assets | |||
Intangible assets | 11 | ||
Property, plant and equipment | 12 | ||
Right-of-use assets | 13 | ||
Investments in joint ventures | 14 | ||
Financial assets at fair value through profit and loss | |||
Deferred tax assets | 15 | ||
Retirement benefit surplus | 16 | ||
Trade and other receivables | 17 | ||
Current assets | |||
Inventories | 18 | ||
Financial assets at fair value through profit and loss | |||
Trade and other receivables | 17 | ||
Current income tax receivable | |||
Cash and cash equivalents | 19 | ||
Total assets |
Represented 1 | |||
2024 | 2023 | ||
Note | £m | £m | |
LIABILITIES | |||
Non-current liabilities | |||
Interest-bearing loans and borrowings | 20 | ( | ( |
Trade and other payables | 21 | ( | ( |
Lease liabilities | 13 | ( | ( |
Deferred tax liabilities | 15 | ( | ( |
Provisions | 22 | ( | ( |
( | ( | ||
Current liabilities | |||
Interest-bearing loans and borrowings | 20 | ( | ( |
Trade and other payables | 21 | ( | ( |
Lease liabilities | 13 | ( | ( |
Provisions | 22 | ( | ( |
( | ( | ||
Total liabilities | ( | ( | |
Net assets | |||
EQUITY | |||
Share capital | 23 | ||
Share premium account | 23 | ||
Retained earnings | |||
Total equity |
2024 | 2023 | ||
Note | £m | £m | |
Cash flows from operating activities | |||
(Loss)/profit for the year attributable to equity shareholders | ( | ||
Adjustments for: | |||
Depreciation on property, plant and equipment | 12 | ||
Depreciation on right-of-use assets | 13 | ||
Retirement benefit obligation administrative expenses | 16 | ||
Net finance expense | 7 | ||
Share-based payment expense | 16 | ||
Share of post-tax losses/(profits) of joint ventures using the equity | |||
method | 14 | ( | |
Impairment of inventories movement | 18 | ||
Net impairment of financial assets | 17 | ||
Income tax (credit)/expense | 8 | ( | |
Operating cash (outflow)/inflow before changes in working capital, provisions and contributions to retirement benefit obligations | ( | ||
(Increase)/decrease in trade and other receivables | ( | ||
Decrease/(increase) in inventories | ( | ||
Increase/(decrease) in trade and other payables and provisions | ( | ||
Contribution to retirement benefit obligations | 16 | ( | ( |
Cash used by operations | ( | ( | |
Finance expense paid | ( | ( | |
Income tax received/(paid) | ( | ||
Net cash outflow from operating activities | ( | ( |
2024 | 2023 | ||
Note | £m | £m | |
Cash flows from investing activities | |||
Purchases of property, plant and equipment | 12 | ( | ( |
Disposal of financial assets at fair value through profit and loss | |||
Funding to joint ventures | ( | ( | |
Repayment of funding from joint ventures | |||
Dividends received from joint ventures | |||
Finance income received | |||
Net cash inflow from investing activities | |||
Cash flows from financing activities | |||
Principal elements of lease payments | 13 | ( | ( |
Dividends paid | 9 | ( | ( |
Net purchase of own shares | ( | ( | |
Proceeds from borrowings | |||
Repayments of borrowings | ( | ||
Sale and leaseback proceeds | |||
Net cash outflow from financing activities | ( | ( | |
Net decrease in cash and cash equivalents | ( | ( | |
Cash and cash equivalents at the beginning of the year | |||
Cash and cash equivalents at the end of the year | 19 |
Fixtures and fittings | 10% |
Computer equipment and non-SaaS software | 20% to 33% |
2024 | 2023 | |
Revenue type | £m | £m |
Open market housing including specification upgrades | 493.5 | 550.0 |
Affordable housing | 79.0 | 88.0 |
Total housing | 572.5 | 638.0 |
Land and commercial sales | 45.7 | 19.5 |
Total revenue | 618.2 | 657.5 |
Timing of revenue recognition | ||
Revenue recognised at a point in time | 525.0 | 552.4 |
Revenue recognised over time | 93.2 | 105.1 |
Total revenue | 618.2 | 657.5 |
Assets and liabilities related to contracts with customers | ||
Contract assets (note 17) | 7.6 | 6.9 |
Contract liabilities (note 21) | (6.9) | (6.0) |
Represented¹ | ||
2024 | 2023 | |
Cost of sales | £m | £m |
Combustible materials charge | (131.7) | (11.3) |
Combustible materials credit | 4.4 | 10.0 |
Net combustible materials charge | (127.3) | (1.3) |
Legal provision and professional fees | (0.4) | (13.0) |
Completed site costs | (25.0) | (6.6) |
Freehold inventories write off | (5.7) | – |
Total cost of sales charge | (158.4) | (20.9) |
Administrative expenses | ||
Aborted transaction costs | (1.6) | – |
Net finance expense | ||
Combustible materials imputed interest | (6.1) | (4.6) |
Share of post-tax profits of joint ventures | ||
Combustible materials credit of joint ventures | – | 0.6 |
Total exceptional charge | (166.1) | (24.9) |
Tax credit on exceptional charge | 48.2 | 6.5 |
Total exceptional charge after tax credit | (117.9) | (18.4) |
2024 | 2023 | ||
Note | £m | £m | |
Inventories expensed in the year | (497.6) | (520.2) | |
Inventories impairment movement in the year | 18 | (2.1) | (7.6) |
Employee costs | 6 | (63.0) | (60.7) |
Depreciation on property, plant and equipment | 12 | (0.4) | (0.5) |
Depreciation on right-of-use assets | 13 | (2.3) | (2.3) |
Joint venture project management fees recognised in other operating income | 27 | 1.9 | 1.9 |
2024 | 2023 | |
£m | £m | |
Proceeds on disposal of part exchange properties | 68.8 | 40.1 |
Rental income | 3.4 | 1.6 |
Joint venture and other management fee income | 3.6 | 3.0 |
75.8 | 44.7 |
2024 | 2023 | |
£m | £m | |
Costs associated with disposal of part exchange properties | 69.9 | 40.9 |
2024 | 2023 | |
£000 | £000 | |
Audit of these consolidated financial statements | 191 | 166 |
Audit of financial statements of subsidiaries pursuant to legislation | 1,529 | 819 |
Other non-audit services | 130 | 154 |
2024 | 2023 | |
Number | Number | |
Development | 704 | 778 |
2024 | 2023 | |
£m | £m | |
Wages and salaries | 52.3 | 50.4 |
Social security costs | 6.0 | 5.8 |
Other pension costs | 2.9 | 3.0 |
Share-based payments | 1.8 | 1.5 |
63.0 | 60.7 |
2024 | 2023 | |
£m | £m | |
Salaries and short-term employee benefits | 4.8 | 3.5 |
Share-based payments | 0.8 | 0.6 |
5.6 | 4.1 |
2024 | 2023 | |
£m | £m | |
Salaries and short-term employee benefits | 2.4 | 1.7 |
Share-based payments | 0.4 | 0.5 |
2.8 | 2.2 |
2024 | 2023 | ||
Note | £m | £m | |
Finance income | |||
Interest income | 2.7 | 2.4 | |
Interest on amounts due from joint ventures | 27 | 0.7 | 1.2 |
Net interest on defined benefit pension scheme | 16 | 0.6 | 0.5 |
4.0 | 4.1 | ||
Finance expense | |||
Interest on bank loans | (6.7) | (5.7) | |
Revolving Credit Facility issue costs | (0.7) | (0.6) | |
Imputed interest on deferred land payables | (5.0) | (3.1) | |
Interest on lease liabilities | 13 | (0.4) | (0.2) |
Imputed interest on combustible materials provision – exceptional | 4 | (6.1) | (4.6) |
(18.9) | (14.2) | ||
Net finance expense | (14.9) | (10.1) |
2024 | 2023 | ||
Note | £m | £m | |
Current tax | |||
UK corporation tax credit/(expense) on (loss)/profit for the year | 3.7 | (4.2) | |
Adjustment in respect of prior periods | 0.5 | 0.7 | |
Total current tax credit/(expense) | 4.2 | (3.5) | |
Deferred tax | |||
Origination and reversal of temporary differences in the year | 36.0 | (1.7) | |
Total deferred tax credit/(charge) | 15 | 36.0 | (1.7) |
Total income tax credit/(expense) in consolidated income statement | 40.2 | (5.2) |
2024 | 2023 | |
£m | £m | |
Reconciliation of tax credit/(expense) in the year | ||
(Loss)/profit before tax | (143.7) | 23.1 |
Tax charge on (loss)/profit at 29.0% (2023: 26.5%) | 41.7 | (6.1) |
Effects of: | ||
Expenses not deductible for tax purposes | (1.9) | (0.8) |
Enhanced tax deductions | 0.3 | 0.3 |
Adjustment in respect of prior periods | 0.5 | 0.7 |
Impact of tax rate change on losses carried back | (0.4) | – |
Impact of RPDT annual allowance and adjustments | – | 0.7 |
Total income tax credit/(expense) in consolidated income statement | 40.2 | (5.2) |
2024 | 2023 | |
£m | £m | |
Current year interim dividend of 1.0 pence per share (2023: 5.5 pence per share) | 2.6 | 14.1 |
Prior year final dividend per share of 11.5 pence per share (2023: 11.5 pence per share) | 29.5 | 29.5 |
32.1 | 43.6 |
2024 | 2023 | |
£m | £m | |
Final dividend for the year ended 31 October 2024 of | ||
(2023: | 3.2 | 29.5 |
Weighted | |||
average | |||
number of | |||
(Loss)/ | ordinary | Per share | |
earnings | shares | amount | |
£m | Number | Pence | |
Year ended 31 October 2024 | |||
Basic loss per share | (103.5) | 256,367,618 | (40.4) |
Dilutive effect of share options | – | 1,608,047 | |
Diluted loss per share | (103.5) | 257,975,665 | (40.4) |
Year ended 31 October 2024 – Pre-exceptional items | |||
Adjusted basic earnings per share | 14.4 | 256,367,618 | 5.6 |
Dilutive effect of share options | – | 1,608,047 | |
Adjusted diluted earnings per share | 14.4 | 257,975,665 | 5.6 |
Year ended 31 October 2023 | |||
Basic earnings per share | 17.9 | 256,131,621 | 7.0 |
Dilutive effect of share options | – | 594,762 | |
Diluted earnings per share | 17.9 | 256,726,383 | 7.0 |
Year ended 31 October 2023 – Pre-exceptional items | |||
(Represented¹) | |||
Adjusted basic earnings per share | 36.3 | 256,131,621 | 14.2 |
Dilutive effect of share options | – | 594,762 | |
Adjusted diluted earnings per share | 36.3 | 256,726,383 | 14.1 |
2024 | 2023 | |
Goodwill | £m | £m |
Cost at beginning and end of the year | 47.7 | 47.7 |
Accumulated impairment | (18.7) | (18.7) |
At beginning and end of the year | 29.0 | 29.0 |
Computer | |||
equipment | |||
Fixtures and | and | ||
fittings | software | Total | |
£m | £m | £m | |
Cost | |||
At 1 November 2022 | 1.7 | 2.9 | 4.6 |
Additions | 1.8 | – | 1.8 |
Disposals | – | (0.7) | (0.7) |
At 31 October 2023 | 3.5 | 2.2 | 5.7 |
Additions | 1.4 | – | 1.4 |
Disposals | (0.8) | (0.2) | (1.0) |
At 31 October 2024 | 4.1 | 2.0 | 6.1 |
Accumulated depreciation | |||
At 1 November 2022 | 1.1 | 2.6 | 3.7 |
Charge for the year | 0.3 | 0.2 | 0.5 |
Disposals | – | (0.7) | (0.7) |
At 31 October 2023 | 1.4 | 2.1 | 3.5 |
Charge for the year | 0.3 | 0.1 | 0.4 |
Disposals | (0.8) | (0.2) | (1.0) |
At 31 October 2024 | 0.9 | 2.0 | 2.9 |
Net book value | |||
At 31 October 2024 | 3.2 | – | 3.2 |
At 31 October 2023 | 2.1 | 0.1 | 2.2 |
At 31 October 2022 | 0.6 | 0.3 | 0.9 |
Office | Other | ||
buildings | leases | Total | |
£m | £m | £m | |
Cost | |||
At 1 November 2022 | 13.1 | 4.5 | 17.6 |
Additions | 2.8 | 1.9 | 4.7 |
Disposals | (7.3) | (1.6) | (8.9) |
At 31 October 2023 | 8.6 | 4.8 | 13.4 |
Additions | 2.8 | 4.3 | 7.1 |
Disposals | (3.6) | (1.4) | (5.0) |
At 31 October 2024 | 7.8 | 7.7 | 15.5 |
Accumulated depreciation | |||
At 1 November 2022 | 11.1 | 2.8 | 13.9 |
Charge for the year | 1.3 | 1.0 | 2.3 |
Disposals | (7.3) | (1.6) | (8.9) |
At 31 October 2023 | 5.1 | 2.2 | 7.3 |
Charge for the year | 1.2 | 1.1 | 2.3 |
Disposals | (3.6) | (1.4) | (5.0) |
At 31 October 2024 | 2.7 | 1.9 | 4.6 |
Net book value | |||
At 31 October 2024 | 5.1 | 5.8 | 10.9 |
At 31 October 2023 | 3.5 | 2.6 | 6.1 |
At 31 October 2022 | 2.0 | 1.7 | 3.7 |
2024 | 2023 | |
£m | £m | |
Non-current | 8.8 | 4.4 |
Current | 3.2 | 2.0 |
Total lease liabilities | 12.0 | 6.4 |
2024 | 2023 | |
£m | £m | |
Depreciation on right-of-use assets | 2.3 | 2.3 |
Interest on lease liabilities | 0.4 | 0.2 |
2024 | 2023 | |
£m | £m | |
Principal element of lease payments | 1.9 | 2.4 |
2024 | 2023 | |
£m | £m | |
Less than one year | 3.8 | 2.2 |
One to five years | 8.2 | 3.2 |
More than five years | 2.5 | 1.6 |
Total | 14.5 | 7.0 |
2024 | 2023 | |
£m | £m | |
Total investments in joint ventures | ||
Crest A2D (Walton Court) LLP | 1.3 | 2.3 |
Elmsbrook (Crest A2D) LLP | 1.2 | 3.5 |
Crest Sovereign (Brooklands) LLP | 5.9 | 4.9 |
Crest Peabody (Turweston) LLP | 0.2 | – |
Other non-material joint ventures | – | – |
Total investments in joint ventures | 8.6 | 10.7 |
Crest | Crest | Other non- | ||||
Crest A2D | Elmsbrook | Sovereign | Peabody | material | ||
(Walton | (Crest A2D) | (Brooklands) | (Turweston) | joint | ||
Court) LLP | LLP | LLP | LLP | ventures | Total | |
2024 | £m | £m | £m | £m | £m | £m |
Summarised statement of financial position | ||||||
Current assets: | ||||||
Cash and cash equivalents | 0.3 | 2.4 | 0.3 | 0.1 | 0.5 | 3.6 |
Inventories | 19.6 | 0.7 | 19.5 | 1.1 | – | 40.9 |
Other current assets | 8.1 | 0.2 | 4.2 | 5.1 | 1.6 | 19.2 |
Current liabilities: | ||||||
Financial liabilities | (21.8) | – | (7.4) | (5.9) | (2.7) | (37.8) |
Other current liabilities | (3.6) | (1.0) | (4.8) | – | (1.1) | (10.5) |
Net assets/(liabilities) | 2.6 | 2.3 | 11.8 | 0.4 | (1.7) | 15.4 |
Reconciliation to carrying | ||||||
amounts | ||||||
Opening net assets/(liabilities) at 1 November 2023 | 4.5 | 6.9 | 9.8 | – | (1.7) | 19.5 |
(Loss)/profit for the year | (2.4) | 0.4 | 2.0 | (0.2) | – | (0.2) |
Capital contribution reserve | 0.5 | – | – | 0.6 | – | 1.1 |
Dividends paid | – | (5.0) | – | – | – | (5.0) |
Closing net assets/(liabilities) at 31 October 2024 | 2.6 | 2.3 | 11.8 | 0.4 | (1.7) | 15.4 |
Crest | Crest | Other non- | ||||
Crest A2D | Elmsbrook | Sovereign | Peabody | material | ||
(Walton | (Crest A2D) | (Brooklands) | (Turweston) | joint | ||
Court) LLP | LLP | LLP | LLP | ventures | Total | |
2024 | £m | £m | £m | £m | £m | £m |
Group's share of closing net | ||||||
assets/(liabilities) at 31 October | ||||||
2024 | 1.3 | 1.2 | 5.9 | 0.2 | (0.9) | 7.7 |
Losses recognised against receivable from joint venture | ||||||
(note 17) | – | – | – | – | 0.9 | 0.9 |
Group’s share in joint venture | 1.3 | 1.2 | 5.9 | 0.2 | – | 8.6 |
Amount due to the Group | ||||||
(note 17) | 11.1 | – | 3.7 | 6.0 | 1.8 | 22.6 |
Amount due from the Group | ||||||
(note 21) | – | – | – | – | 0.1 | 0.1 |
Summarised income statement | ||||||
for the 12 months ending | ||||||
31 October 2024 | ||||||
Revenue | 56.1 | 8.2 | 15.4 | – | – | 79.7 |
Expenditure | (57.5) | (7.8) | (13.1) | – | – | (78.4) |
Operating (loss)/profit before finance expense | (1.4) | 0.4 | 2.3 | – | – | 1.3 |
Finance expense | (1.0) | – | (0.3) | (0.2) | – | (1.5) |
Pre-tax and post-tax (loss)/profit | ||||||
for the year | (2.4) | 0.4 | 2.0 | (0.2) | – | (0.2) |
Group’s share in joint venture | ||||||
(loss)/profit for the year | (1.2) | 0.2 | 1.0 | (0.1) | – | (0.1) |
Crest | Crest | Other non- | ||||
Crest A2D | Elmsbrook | Sovereign | Peabody | material | ||
(Walton | (Crest A2D) | (Brooklands) | (Turweston) | joint | ||
Court) LLP | LLP | LLP | LLP | ventures | Total | |
2023 | £m | £m | £m | £m | £m | £m |
Summarised statement of financial position | ||||||
Current assets: | ||||||
Cash and cash equivalents | 0.2 | 6.0 | 0.4 | – | 0.2 | 6.8 |
Inventories | 64.8 | 4.6 | 16.7 | – | – | 86.1 |
Other current assets | 0.2 | 1.0 | 1.9 | 5.3 | 2.0 | 10.4 |
Current liabilities: | ||||||
Financial liabilities | (52.0) | (1.4) | (1.1) | (0.3) | – | (54.8) |
Other current liabilities | (5.7) | (3.3) | (8.1) | (5.0) | (3.9) | (26.0) |
Non-current liabilities | ||||||
Financial liabilities | (3.0) | – | – | – | – | (3.0) |
Net assets/(liabilities) | 4.5 | 6.9 | 9.8 | – | (1.7) | 19.5 |
Reconciliation to carrying | ||||||
amounts | ||||||
Opening net assets/(liabilities) at 1 November 2022 | 6.7 | 6.5 | 4.6 | – | (2.9) | 14.9 |
(Loss)/profit for the year | (3.2) | 3.4 | 5.2 | – | 1.2 | 6.6 |
Capital contribution reserve | 1.0 | – | – | – | – | 1.0 |
Dividends paid | – | (3.0) | – | – | – | (3.0) |
Closing net assets/(liabilities) at 31 October 2023 | 4.5 | 6.9 | 9.8 | – | (1.7) | 19.5 |
Crest | Crest | Other non- | ||||
Crest A2D | Elmsbrook | Sovereign | Peabody | material | ||
(Walton | (Crest A2D) | (Brooklands) | (Turweston) | joint | ||
Court) LLP | LLP | LLP | LLP | ventures | Total | |
2023 | £m | £m | £m | £m | £m | £m |
Group's share of closing net | ||||||
assets/(liabilities) at 31 October | ||||||
2023 | 2.3 | 3.5 | 4.9 | – | (0.9) | 9.8 |
Fully provided in the Group | ||||||
financial statements (note 22) | – | – | – | – | 0.9 | 0.9 |
Group’s share in joint venture | 2.3 | 3.5 | 4.9 | – | – | 10.7 |
Amount due to the Group | ||||||
(note 17) | 27.4* | 1.4 | 0.4 | 0.3 | – | 29.5 |
Amount due from the Group | ||||||
(note 21) | – | – | – | – | 0.7 | 0.7 |
Summarised income statement | ||||||
for the 12 months ending | ||||||
31 October 2023 | ||||||
Revenue | 0.9 | 21.1 | 47.2 | – | – | 69.2 |
Expenditure | (2.6) | (17.7) | (41.1) | – | – | (61.4) |
Expenditure – exceptional item | ||||||
(note 4) | – | – | – | – | 1.2 | 1.2 |
Operating (loss)/profit before finance expense | (1.7) | 3.4 | 6.1 | – | 1.2 | 9.0 |
Finance expense | (1.5) | – | (0.9) | – | – | (2.4) |
Pre-tax and post-tax (loss)/profit | ||||||
for the year | (3.2) | 3.4 | 5.2 | – | 1.2 | 6.6 |
Group’s share in joint venture | ||||||
(loss)/profit for the year | (1.6) | 1.7 | 2.6 | – | 0.6 | 3.3 |
Subsidiary | Nature of business |
CN Finance plc | Holding company (including group financing) |
Crest Nicholson plc | Holding company |
Crest Nicholson Operations Limited | Residential and commercial property development |
Share- | Other | ||||
Inventories | based | temporary | |||
fair value | payments | Tax losses | differences | Total | |
Deferred tax assets | £m | £m | £m | £m | £m |
At 1 November 2022 | 1.5 | 0.5 | – | 2.8 | 4.8 |
Consolidated income statement movements | (0.4) | (0.1) | – | (0.8) | (1.3) |
Equity movements | – | (0.2) | – | – | (0.2) |
At 31 October 2023 | 1.1 | 0.2 | – | 2.0 | 3.3 |
Consolidated income statement movements | (0.2) | – | 36.0 | 0.5 | 36.3 |
Equity movements | – | 0.1 | – | – | 0.1 |
At 31 October 2024 | 0.9 | 0.3 | 36.0 | 2.5 | 39.7 |
Pension | ||
surplus | Total | |
Deferred tax liabilities | £m | £m |
At 1 November 2022 | (3.2) | (3.2) |
Consolidated income statement movements | (0.4) | (0.4) |
Equity movements | 1.1 | 1.1 |
At 31 October 2023 | (2.5) | (2.5) |
Consolidated income statement movements | (0.3) | (0.3) |
Equity movements | (2.1) | (2.1) |
At 31 October 2024 | (4.9) | (4.9) |
2024 | 2023 | 2022 | |
£m | £m | £m | |
The amounts recognised in the consolidated statement of financial | |||
position are as follows: | |||
Fair value of scheme assets | 145.1 | 141.3 | 160.0 |
Present value of scheme liabilities | (125.6) | (131.3) | (148.9) |
Net surplus amount recognised at year end | 19.5 | 10.0 | 11.1 |
Deferred tax liability recognised at year end within non-current liabilities | (4.9) | (2.5) | (3.2) |
2024 | 2023 | |
£m | £m | |
Service cost | ||
Administrative expenses | (0.7) | (0.6) |
Interest income | 0.6 | 0.5 |
Recognised in the consolidated income statement | (0.1) | (0.1) |
2024 | 2023 | |
£m | £m | |
Remeasurements of the net liability | ||
Return on Scheme assets | 3.2 | (18.5) |
(Losses)/gains arising from changes in financial assumptions | (4.6) | 12.5 |
Gains arising from changes in demographic assumptions | 3.9 | 6.1 |
Experience gains/(losses) | 6.0 | (2.6) |
Actuarial gains/(losses) recorded in the consolidated statement of comprehensive income | 8.5 | (2.5) |
Total defined benefit scheme gains/(losses) | 8.4 | (2.6) |
2024 | 2023 | |
% | % | |
The principal actuarial assumptions used | ||
were: | ||
Liability discount rate | 5.3 | 5.6 |
Inflation assumption – RPI | 3.2 | 3.3 |
Inflation assumption – CPI | 2.7 | 2.7 |
Revaluation of deferred pensions | 2.7 | 2.7 |
Increases for pensions in payment | ||
Benefits accrued in excess of GMP pre-1997 | 3.0 | 3.0 |
Benefits accrued post-1997 | 3.0 | 3.1 |
Proportion of employees opting for early | ||
retirement | 0.0 | 0.0 |
Proportion of employees commuting pension | ||
for cash | 100.0 | 100.0 |
Mortality assumption – pre-retirement | AC00 | AC00 |
Mortality assumption – male and female post- | Male/female pensioners: | S3PA light base tables |
retirement | 103%/103% S3PA base tables. | (males and females) |
Male/female dependants: | projected in line with | |
103%/100% S3DA base tables. | CMI_2022 | |
Projected in line with CMI_2023 | core model with core | |
core projections and core | parameters (Sk = | |
parameters (Sk = 7.0, an initial | 7.0, an initial addition of | |
addition of 0.25%, w2020 = | 0.25%, w2020 | |
w2021 = 0%, and w2022 = | and w2021 set to zero | |
w2023 = 15%) and a long-term | and 2022 set to 25%) and | |
improvement rate of 1.25% | with a long-term rate of | |
improvement of 1.25% p.a |
2024 | 2023 | |
Years | Years | |
Future expected lifetime of current pensioner at age 65 | ||
Male aged 65 at year end | 21.4 | 22.9 |
Female aged 65 at year end | 23.9 | 24.6 |
Future expected lifetime of future pensioner at age 65 | ||
Male aged 45 at year end | 22.7 | 24.1 |
Female aged 45 at year end | 25.3 | 25.9 |
2024 | 2023 | |
£m | £m | |
Changes in the present value of assets over the year | ||
Fair value of assets at beginning of the year | 141.3 | 160.0 |
Interest income | 7.7 | 7.5 |
Return on assets (excluding amount included in net interest income) | 3.2 | (18.5) |
Contributions from the employer | 1.1 | 1.5 |
Benefits paid | (7.5) | (8.6) |
Administrative expenses | (0.7) | (0.6) |
Fair value of assets at end of the year | 145.1 | 141.3 |
Actual return on assets over the year | 10.9 | (10.9) |
2024 | 2023 | |
£m | £m | |
Changes in the present value of liabilities over the year | ||
Liabilities at beginning of the year | (131.3) | (148.9) |
Interest cost | (7.1) | ( 7.0) |
Remeasurement gains/(losses) | ||
(Losses)/gains arising from changes in financial assumptions | (4.6) | 12.5 |
Gains arising from changes in demographic assumptions | 3.9 | 6.1 |
Experience gains/(losses) | 6.0 | (2.6) |
Benefits paid | 7.5 | 8.6 |
Liabilities at end of the year | (125.6) | (131.3) |
2024 | 2023 | |
£m | £m | |
Split of the Scheme's liabilities by category of membership | ||
Deferred pensioners | (47.2) | (57.8) |
Pensions in payment | (78.4) | (73.5) |
(125.6) | (131.3) |
2024 | 2023 | |
Years | Years | |
Average duration of the Scheme's liabilities at end of the year | 11.0 | 12.0 |
This can be subdivided as follows: | ||
Deferred pensioners | 15.0 | 16.0 |
Pensions in payment | 9.0 | 9.0 |
2024 | 2023 | |
£m | £m | |
Major categories of scheme assets | ||
Return seeking | ||
Overseas equities | 8.6 | 2.4 |
Other (hedge funds, multi asset strategy and absolute return funds) | 40.1 | 23.6 |
48.7 | 26.0 | |
Debt instruments | ||
Corporates | 35.8 | 11.8 |
Liability-driven investing | 38.4 | 44.1 |
74.2 | 55.9 | |
Other Cash (including liquidity fund) | 18.3 | 55.9 |
Insured annuities | 3.9 | 3.5 |
22.2 | 59.4 | |
Total market value of assets | 145.1 | 141.3 |
20 Feb | 04 Aug | 08 Feb | 28 Jan | 25 Aug | 06 Mar | 07 Aug | 27 Jan | 05 Feb | 17 Jun | 17 Jun | 17 Jun | 17 Jun | |
Date of grant | 2020 | 2020 | 2021 | 2022 | 2022 | 2023 | 2023 | 2023 | 2024 | 2024 | 2024 | 2024 | 2024 |
Options granted | 1,125,531 | 7,298 | 1,328,192 | 1,341,918 | 23,955 | 29,462 | 508 | 1,771,417 | 1,487,313 | 498,628 | 224,909 | 138,037 | 97,544 |
Fair value at measurement date | £4.28 | £1.53 | £2.50 | £2.10 | £1.59 | £2.75 | £2.46 | £1.88 | £1.62 | £1.92 | £1.47 | £1.30 | £2.48 |
Share price on date of grant | £5.16 | £1.85 | £3.23 | £3.07 | £2.33 | £2.32 | £2.14 | £2.45 | £2.04 | £2.48 | £2.48 | £2.48 | £2.48 |
Exercise price | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
Vesting period | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | May 26 | Mar 25 | Mar 26 |
Expected dividend yield | 6.40% | 6.40% | 4.30% | 5.30% | 5.30% | N/A | N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Expected volatility | 30.00% | 30.00% | 40.00% | 40.00% | 40.00% | N/A | N/A | 45.00% | 40.00% | 40.00% | 40.00% | 40.00% | 40.00% |
Risk-free interest rate | 0.45% | 0.45% | 0.03% | 0.97% | 0.97% | N/A | N/A | 3.23% | 4.05% | 4.12% | 4.12% | 4.12% | 4.12% |
Binomial/ | Binomial/ | Binomial/ | Binomial/ | Binomial/ | Binomial/ | Binomial/ | Binomial/ | ||||||
Monte | Monte | Monte | Monte | Monte | Monte | Monte | Monte | ||||||
Valuation model | Binomial | Binomial | Carlo | Carlo | Carlo | N/A | N/A | Carlo | Carlo | Carlo | Carlo | Carlo | Binomial |
Contractual life from | 20.02.20 | 04.08.20 | 08.02.21 | 28.01.22 | 25.08.22 | 06.03.23 | 07.08.23 | 27.01.23 | 05.02.24 | 17.06.24 | 17.06.24 | 17.06.24 | 17.06.24 |
Contractual life to | 19.02.30 | 03.08.30 | 07.02.31 | 27.02.32 | 27.02.32 | 19.02.30 | 03.08.30 | 26.01.33 | 05.02.34 | 16.06.34 | 16.06.34 | 16.06.34 | 16.06.34 |
Number | Number | Number | Number | Number | Number | Number | Number | Number | Number | Number | Number | Number | Total Number | |
of options | of options | of options | of options | of options | of options | of options | of options | of options | of options | of options | of options | of options | of options | |
Movements in the year | ||||||||||||||
Outstanding at 1 November 2022 | 891,970 | 7,298 | 1,197,676 | 1,312,475 | 23,955 | – | – | – | – | – | – | – | – | 3,433,374 |
Granted during the year | – | – | – | – | – | 29,462 | 508 | 1,771,407 | – | – | – | – | – | 1,801,377 |
Exercised during the year | (417,308) | (3,948) | – | – | – | (29,462) | (508) | – | – | – | – | – | – | (451,226) |
Lapsed during the year | (474,662) | (3,350) | (167,438) | (181,150) | – | – | – | (201,028) | – | – | – | – | – | (1,027,628) |
Outstanding at 31 October 2023 | – | – | 1,030,238 | 1,131,325 | 23,955 | – | – | 1,570,379 | – | – | – | – | – | 3,755,897 |
Granted during the year | – | – | – | – | – | – | – | – | 1,487,313 | 498,628 | 224,909 | 138,037 | 97,544 | 2,446,431 |
Lapsed during the year | – | – | (1,030,238) | (252,040) | – | – | – | (455,292) | (92,844) | – | – | – | – | (1,830,414) |
Outstanding at 31 October 2024 | – | – | – | 879,285 | 23,955 | – | – | 1,115,087 | 1,394,469 | 498,628 | 224,909 | 138,037 | 97,544 | 4,371,914 |
Exercisable at 31 October 2024 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Exercisable at 31 October 2023 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
£m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | Total £m | |
Charge to income for the current year | – | – | – | 0.1 | – | – | – | 0.4 | 0.3 | 0.1 | 0.1 | 0.1 | – | 1.1 |
Charge to income for the prior year | 0.1 | – | – | 0.1 | – | 0.1 | – | 0.3 | – | – | – | – | – | 0.6 |
30 Jul | 07 Aug | 03 Aug | 02 Aug | 28 Jul | 13 Sep | |
Date of grant | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Options granted | 935,208 | 1,624,259 | 256,132 | 975,549 | 1,938,156 | 663,354 |
Fair value at measurement date | £0.54 | £0.36 | £1.15 | £0.66 | £1.51 | £0.40 |
Share price on date of grant | £3.68 | £1.94 | £4.14 | £2.67 | £2.19 | £1.98 |
Exercise price | £2.86 | £1.70 | £3.42 | £1.94 | £1.51 | £1.71 |
Vesting period | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years |
Expected dividend yield | 8.96% | 5.20% | 1.98% | 5.63% | 7.78% | 8.60% |
Expected volatility | 35.00% | 40.00% | 45.30% | 42.20% | 41.60% | 44.10% |
Risk-free interest rate | 0.38% | -0.08% | 0.14% | 1.62% | 4.63% | 3.51% |
Valuation model | Binomial | Binomial | Binomial | Binomial | Binomial | Binomial |
Contractual life from | 01.09.19 | 01.09.20 | 01.09.21 | 01.09.22 | 01.09.23 | 01.10.24 |
Contractual life to | 01.03.23 | 01.03.24 | 01.03.25 | 01.03.26 | 01.03.27 | 01.04.28 |
30 Jul | 07 Aug | 03 Aug | 02 Aug | 28 Jul | 13 Sep | |||
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||
Weighted | ||||||||
Number of | Number of | Number of | Number of | Number of | Number of | Total number | average | |
Movements in the year | options | options | options | options | options | options | of options | exercise price |
Outstanding at 1 November 2022 | 96,832 | 907,769 | 84,131 | 912,557 | – | – | 2,001,289 | £1.94 |
Granted during the year | – | 25 | – | – | 1,938,156 | – | 1,938,156 | £1.51 |
Exercised during the year | – | (522,976) | – | – | – | – | (522,976) | £1.70 |
Lapsed during the year | (96,832) | (61,983) | (41,201) | (486,485) | (158,774) | – | (845,275) | £2.02 |
Outstanding at 31 October 2023 | – | 322,810 | 42,930 | 426,072 | 1,779,382 | – | 2,571,194 | £1.64 |
Granted during the year | – | – | – | – | – | 663,354 | 663,354 | £1.71 |
Exercised during the year | – | (198,624) | – | (3,581) | (4,965) | – | (207,170) | £1.70 |
Lapsed during the year | – | (124,186) | (9,943) | (231,870) | (489,591) | (27,572) | (883,162) | £1.68 |
Outstanding at 31 October 2024 | – | – | 32,987 | 190,621 | 1,284,826 | 635,782 | 2,144,216 | £1.64 |
Exercisable at 31 October 2024 | – | – | 32,987 | – | – | – | 32,987 | |
Exercisable at 31 October 2023 | – | 322,810 | – | – | – | – | 322,810 |
Total | |||||||
£m | £m | £m | £m | £m | £m | £m | |
Charge to income for the current year | – | – | – | 0.1 | 0.3 | – | 0.4 |
Charge to income for the prior year | – | 0.1 | – | 0.3 | 0.1 | – | 0.5 |
28 Feb | 28 Jan | 09 Feb | 06 Mar | 06 Mar | 27 Jan | 05 Feb | |
Date of grant | 2020 | 2022 | 2022 | 2023 | 2023 | 2023 | 2024 |
Options granted | 20,956 | 230,605 | 58,848 | 151 | 2,897 | 340,125 | 3,234 |
Fair value at measurement date | £4.52 | £2.76 | £2.76 | £2.75 | £2.53 | £2.44 | £2.02 |
Share price on date of grant | £4.52 | £3.06 | £3.27 | £2.32 | £2.32 | £2.45 | £2.04 |
Exercise price | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 |
Vesting period | 3 years | 3 years | 1 year | N/A | N/A | 3/1 year | N/A |
Expected dividend yield and volatility | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Risk-free interest rate | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Valuation model | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Contractual life from | 28.02.20 | 28.01.22 | 09.02.22 | 06.03.23 | 06.03.23 | 27.01.23 | 05.02.24 |
Contractual life to | 27.02.30 | 27.01.32 | 08.02.32 | 27.02.30 | 08.02.32 | 26.01.33 | 26.01.34 |
28 Feb | 28 Jan | 09 Feb | 06 Mar | 06 Mar | 27 Jan | 05 Feb | ||
2020 | 2022 | 2022 | 2023 | 2023 | 2023 | 2023 | ||
Number of | Number of | Number of | Number of | Number of | Number of | Number of | Total number | |
Movements in the year | options | options | options | options | options | options | options | of options |
Outstanding at 1 November 2022 | 2,260 | 230,605 | 58,848 | – | – | – | – | 291,713 |
Granted during the year | – | – | – | 151 | 2,897 | 340,125 | – | 343,173 |
Exercised during the year | (2,260) | – | (48,374) | (151) | (2,897) | – | – | (53,682) |
Lapsed during the year | – | – | (10,474) | – | – | (21,108) | – | (31,582) |
Outstanding at 31 October 2023 | – | 230,605 | – | – | – | 319,017 | – | 549,622 |
Granted during the year | – | – | – | – | – | – | 3,234 | 3,234 |
Exercised during the year | – | – | – | – | – | (37,720) | (3,234) | (40,954) |
Lapsed during the year | – | (41,328) | – | – | – | (50,911) | – | (92,239) |
Outstanding at 31 October 2024 | – | 189,277 | – | – | – | 230,386 | – | 419,663 |
Exercisable at 31 October 2024 | – | – | – | – | – | – | – | – |
Exercisable at 31 October 2023 | – | – | – | – | – | – | – | – |
Total | ||||||||
£m | £m | £m | £m | £m | £m | £m | £m | |
Charge to income for the current year | – | – | – | – | – | 0.2 | – | 0.2 |
Charge to income for the prior year | – | 0.2 | – | – | – | 0.2 | – | 0.4 |
2024 | 2023 | |
Number of | Number of | |
Movements in the year | options | options |
Outstanding at beginning of the year | 6,876,713 | 5,726,376 |
Granted during the year | 3,113,019 | 4,082,706 |
Exercised during the year | (248,124) | (1,027,884) |
Lapsed during the year | (2,805,815) | (1,904,485) |
Outstanding at end of the year | 6,935,793 | 6,876,713 |
Exercisable at end of the year | 32,987 | 322,810 |
2024 | 2023 | |
£m | £m | |
Charge to income for share incentive schemes | 1.7 | 1.5 |
Chief Executive Officer buy-out arrangement¹ | 0.1 | – |
Charge to income for the year | 1.8 | 1.5 |
Trade | Trade | Trade | Trade | |||
and other | and other | and other | and other | |||
receivables | receivables | receivables | receivables | |||
before | after | before | after | |||
expected | Expected | expected | expected | Expected | expected | |
credit loss | credit loss | credit loss | credit loss | credit loss | credit loss | |
2024 | 2024 | 2024 | 2023 | 2023 | 2023 | |
£m | £m | £m | £m | £m | £m | |
Non-current | ||||||
Trade receivables | 12.6 | – | 12.6 | 4.6 | (0.1) | 4.5 |
Due from joint ventures | – | – | – | 1.5 | – | 1.5 |
Other receivables | 2.0 | – | 2.0 | – | – | – |
14.6 | – | 14.6 | 6.1 | (0.1) | 6.0 | |
Current | ||||||
Trade receivables | 51.0 | (1.4) | 49.6 | 57.1 | (0.7) | 56.4 |
Contract assets | 7.7 | (0.1) | 7.6 | 6.9 | – | 6.9 |
Due from joint ventures | 22.7 | (0.1) | 22.6 | 28.1 | (0.1) | 28.0 |
Other receivables | 15.9 | (0.1) | 15.8 | 27.0 | (0.2) | 26.8 |
Prepayments and accrued | ||||||
income | 2.5 | – | 2.5 | 1.9 | – | 1.9 |
99.8 | (1.7) | 98.1 | 121.0 | (1.0) | 120.0 | |
Non-current and current | 114.4 | (1.7) | 112.7 | 127.1 | (1.1) | 126.0 |
2024 | 2023 | |
Movements in total loss allowance for expected credit losses | £m | £m |
At beginning of the year | 1.1 | 0.5 |
Charged in the year | 0.7 | 0.7 |
Released in the year | (0.1) | (0.1) |
At end of the year | 1.7 | 1.1 |
2024 | 2023 | |
Maturity of non-current receivables: | £m | £m |
Due between one and two years | 14.6 | 5.8 |
Due between two and five years | – | 0.2 |
Due after five years | – | – |
14.6 | 6.0 |
Represented¹ | ||
2024 | 2023 | |
£m | £m | |
Land | 670.2 | 679.4 |
Work-in-progress | 334.1 | 361.3 |
Completed buildings including show homes | 102.9 | 89.6 |
Part exchange inventories | 30.2 | 34.5 |
1,137.4 | 1,164.8 |
2024 | 2023 | |
£m | £m | |
At beginning of the year | 20.2 | 12.6 |
NRV charged in the year | 14.2 | 13.4 |
NRV used in the year | (12.1) | (5.8) |
Total movement in NRV in the year | 2.1 | 7.6 |
At end of the year | 22.3 | 20.2 |
2024 | Movement | 2023 | |
£m | £m | £m | |
Cash and cash equivalents | 73.8 | (88.8) | 162.6 |
Bank loans and senior loan notes | (82.3) | 15.4 | (97.7) |
Net (debt)/cash | (8.5) | (73.4) | 64.9 |
2024 | 2023 | |
£m | £m | |
Non-current | ||
Senior loan notes | 65.0 | 85.0 |
Revolving credit and senior loan notes issue costs | (1.8) | (1.5) |
63.2 | 83.5 | |
Current | ||
Senior loan notes | 20.0 | 15.0 |
Revolving credit and senior loan notes issue costs | (0.9) | (0.8) |
19.1 | 14.2 |
Represented 1 | ||
2024 | 2023 | |
£m | £m | |
Non-current | ||
Land payables on contractual terms | 31.8 | 64.7 |
Other payables | 1.7 | 2.0 |
Contract liabilities | – | 0.3 |
Accruals and deferred income | 8.8 | 2.7 |
42.3 | 69.7 | |
Current | ||
Land payables on contractual terms | 99.8 | 140.8 |
Other trade payables | 67.8 | 61.8 |
Contract liabilities | 6.9 | 5.7 |
Amounts due to joint ventures | 0.1 | 0.7 |
Taxes and social security costs | 1.7 | 1.7 |
Other payables | 1.1 | 1.1 |
Accruals and deferred income | 107.8 | 116.8 |
285.2 | 328.6 |
Completed | ||||||
Combustible | Legal | site | Joint | Other | ||
materials | provision | provisions | ventures | provisions | Total | |
£m | £m | £m | £m | £m | £m | |
At 1 November 2022 | 140.8 | – | – | 1.2 | 1.0 | 143.0 |
Provided in the year | 12.0 | 13.0 | – | – | 0.4 | 25.4 |
Utilised in the year | (12.6) | – | – | – | (0.6) | (13.2) |
Released in the year | – | – | – | – | (0.2) | (0.2) |
Imputed interest | 4.6 | – | – | – | – | 4.6 |
Funding commitment change | – | – | – | (0.3) | – | (0.3) |
At 31 October 2023 | ||||||
as previously presented | 144.8 | 13.0 | – | 0.9 | 0.6 | 159.3 |
Represented 1 | – | – | 9.8 | – | – | 9.8 |
At 31 October 2023 as presented | 144.8 | 13.0 | 9.8 | 0.9 | 0.6 | 169.1 |
Provided in the year | 131.7 | – | 21.5 | – | 0.3 | 153.5 |
Utilised in the year | (33.3) | – | (4.0) | – | – | (37.3) |
Released in the year | – | – | (3.7) | – | (0.2) | (3.9) |
Imputed interest | 6.1 | – | – | – | – | 6.1 |
Funding commitment change | – | – | – | (0.9) | – | (0.9) |
At 31 October 2024 | 249.3 | 13.0 | 23.6 | – | 0.7 | 286.6 |
At 31 October 2024 | ||||||
Non-current | 181.5 | – | 10.7 | – | 0.3 | 192.5 |
Current | 67.8 | 13.0 | 12.9 | – | 0.4 | 94.1 |
249.3 | 13.0 | 23.6 | – | 0.7 | 286.6 | |
At 31 October 2023 | ||||||
Non-current (represented¹) | 73.6 | – | 1.4 | – | 0.2 | 75.2 |
Current (represented¹) | 71.2 | 13.0 | 8.4 | 0.9 | 0.4 | 93.9 |
144.8 | 13.0 | 9.8 | 0.9 | 0.6 | 169.1 |
Shares | Nominal | Share premium | ||
issued | value | Share capital | account | |
Number | Pence | £ | £ | |
Ordinary shares as at 1 November 2022, 31 October 2023 and 31 October 2024 | 256,920,539 | 5 | 12,846,027 | 74,227,216 |
Carrying | Contractual | Within | Within | Within | More than | |
value | cash flows | 1 year | 1 to 2 years | 2 to 3 years | 3 years | |
2024 | £m | £m | £m | £m | £m | £m |
Senior loan notes | 85.0 | 94.1 | 23.1 | 2.4 | 52.4 | 16.2 |
Financial liabilities carrying no interest | 326.7 | 332.8 | 280.8 | 36.1 | 13.4 | 2.5 |
At 31 October 2024 | 411.7 | 426.9 | 303.9 | 38.5 | 65.8 | 18.7 |
Carrying | Contractual | Within | Within | Within | More than | |
value | cash flows | 1 year | 1 to 2 years | 2 to 3 years | 3 years | |
2023 | £m | £m | £m | £m | £m | £m |
Senior loan notes | 100.0 | 112.5 | 18.5 | 23.1 | 2.4 | 68.5 |
Financial liabilities carrying no interest (Represented¹) | 391.6 | 399.0 | 325.1 | 42.7 | 28.3 | 2.9 |
At 31 October 2023 | ||||||
(Represented¹) | 491.6 | 511.5 | 343.6 | 65.8 | 30.7 | 71.4 |
Represented 1 | ||
2024 | 2023 | |
£m | £m | |
Sterling bank borrowings, loan notes and long-term creditors | ||
Financial liabilities carrying interest | 85.0 | 100.0 |
Financial liabilities carrying no interest | 326.7 | 391.6 |
411.7 | 491.6 |
Represented 1 | ||
2024 | 2023 | |
£m | £m | |
The maturity of the financial liabilities is: | ||
Repayable within one year | 297.6 | 335.6 |
Repayable between one and two years | 34.5 | 60.3 |
Repayable between two and five years | 77.0 | 78.9 |
Repayable after five years | 2.6 | 16.8 |
411.7 | 491.6 |
Nominal | Face | Carrying | ||
interest | value | value | ||
2024 | rate | £m | £m | Maturity |
Current | ||||
Senior loan notes | 3.32% | 20.0 | 20.0 | 2025 |
Non-current | ||||
Senior loan notes | 3.62%–3.87% | 65.0 | 65.0 | 2026–2029 |
Total interest-bearing loans | 85.0 | 85.0 |
Nominal | Face | Carrying | ||
interest | value | value | ||
2023 | rate | £m | £m | Maturity |
Current | ||||
Senior loan notes | 3.15% | 15.0 | 15.0 | 2024 |
Non-current | ||||
Senior loan notes | 3.32%–3.87% | 85.0 | 85.0 | 2025–2029 |
Total interest-bearing loans | 100.0 | 100.0 |
2024 | 2023 | |
£m | £m | |
Financial assets | ||
Sterling cash deposits | 73.8 | 162.6 |
Trade receivables | 62.2 | 60.9 |
Amounts due from joint ventures | 22.6 | 29.5 |
Other receivables | 12.5 | 22.7 |
Total financial assets at amortised cost | 171.1 | 275.7 |
Financial assets at fair value through profit and loss | 3.3 | 3.7 |
Total financial assets | 174.4 | 279.4 |
2024 | 2023 | |
£m | £m | |
Financial liabilities | ||
Senior loan notes | 85.0 | 100.0 |
Land payables on contractual terms carrying no interest | 131.6 | 205.5 |
Amounts due to joint ventures | 0.1 | 0.7 |
Lease liabilities | 12.0 | 6.4 |
Other trade payables | 67.8 | 61.8 |
Other payables | 2.8 | 3.1 |
Accruals (represented¹) | 112.4 | 114.1 |
Total financial liabilities at amortised cost (represented¹) | 411.7 | 491.6 |
2024 | 2023 | |
£m | £m | |
Cash and cash equivalents | 73.8 | 162.6 |
Non-current Interest-bearing loans and borrowings | (63.2) | (83.5) |
Current Interest-bearing loans and borrowings | (19.1) | (14.2) |
Net (debt)/cash | (8.5) | 64.9 |
Land payables on contractual terms carrying no interest | (131.6) | (205.5) |
Net debt and land creditors | (140.1) | (140.6) |
2024 | 2023 | |
£m | £m | |
Interest income on joint venture funding | 0.7 | 1.2 |
Project management fees recognised | 1.9 | 1.9 |
Amounts due from joint ventures, net of expected credit losses | 22.6 | 29.5 |
Amounts due to joint ventures | 0.1 | 0.7 |
Funding to joint ventures | (13.1) | (13.0) |
Repayment of funding from joint ventures | 36.4 | 11.7 |
Dividends received from joint ventures | 2.5 | 1.5 |
Voting | ||||
rights and | ||||
share- | ||||
holding | ||||
Registered | Active/ | Year end | (direct or | |
Entity name | office 1 | dormant | date | indirect) |
Bath Riverside Estate Management Company Limited | 2 | Dormant | 31 October | 100% |
Bath Riverside Liberty Management Company Limited | 2 | Dormant | 31 October | 100% |
Castle Bidco Home Loans Limited | 1 | Dormant | 31 October | 100% |
Brightwells Residential 1 Company Limited | 1 | Dormant | 31 October | 100% |
Bristol Parkway North Limited | 1 | Dormant | 31 October | 100% |
Building 7 Harbourside Management Company Limited | 2 | Active 31 December | 58.33% | |
Buildings 3A, 3B and 4 Harbourside Management | ||||
Company Limited | 2 | Active 31 December | 83.33% | |
Clevedon Developments Limited | 1 | Dormant | 31 October | 100% |
Clevedon Investment Limited | 1 | Active | 31 October | 100% |
CN Assets Limited | 1 | Dormant | 31 October | 100% |
CN Finance plc 2 | 1 | Active | 31 October | 100% |
CN Nominees Limited | 1 | Dormant | 31 October | 100% |
CN Properties Limited | 1 | Dormant | 31 October | 100% |
CN Secretarial Limited | 1 | Dormant | 31 October | 100% |
CN Shelf 2 LLP | 1 | Dormant | 31 October | 100% |
CN Shelf 3 LLP | 1 | Dormant | 31 October | 100% |
Crest (Claybury) Limited | 1 | Dormant | 31 October | 100% |
Crest Developments Limited | 1 | Dormant | 31 October | 100% |
Crest Estates Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Eastern) Limited | 1 | Dormant | 31 October | 100% |
Voting | ||||
rights and | ||||
share- | ||||
holding | ||||
Registered | Active/ | Year end | (direct or | |
Entity name | office 1 | dormant | date | indirect) |
Crest Homes (Midlands) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Nominees) Limited | 1 | Active | 31 October | 100% |
Crest Homes (Nominees No. 2) Limited | 1 | Active | 31 October | 100% |
Crest Homes (Northern) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (South East) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (South West) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (South) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Wessex) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes (Westerham) Limited | 1 | Dormant | 31 October | 100% |
Crest Homes Limited | 1 | Dormant | 31 October | 100% |
Crest Manhattan Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Bath) Holdings Limited | 1 | Active | 31 October | 100% |
Crest Nicholson (Chiltern) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Eastern) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Epsom) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Henley-on-Thames) Limited | 1 | Active | 31 October | 100% |
Crest Nicholson (Highlands Farm) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Londinium) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Midlands) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Peckham) Limited | 1 | Active | 31 October | 100% |
Crest Nicholson (South East) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (South West) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (South) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson (Stotfold) Limited | 1 | Active | 31 October | 100% |
Voting | ||||
rights and | ||||
share- | ||||
holding | ||||
Registered | Active/ | (direct or | ||
Entity name | office 1 | dormant Year end date | indirect) | |
Crest Nicholson Developments (Chertsey) Limited | 1 | Active | 31 October | 100% |
Crest Nicholson Operations Limited | 1 | Active | 31 October | 100% |
Crest Nicholson Pension Trustee Limited | 1 | Dormant | 31 January | 100% |
Crest Nicholson plc | 1 | Active | 31 October | 100% |
Crest Nicholson Projects Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Properties Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Regeneration Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential (London) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential (Midlands) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential (South East) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential (South) Limited | 1 | Dormant | 31 October | 100% |
Crest Nicholson Residential Limited | 1 | Active | 31 October | 100% |
Crest Nicholson (Wheatley) LLP | 1 | Active | 31 October | 100% |
Crest Partnership Homes Limited | 1 | Dormant | 31 October | 100% |
Crest Strategic Projects Limited | 1 | Dormant | 31 October | 100% |
Eastern Perspective Management Company Limited | 1 | Dormant | 31 October | 100% |
Essex Brewery (Walthamstow) LLP | 1 | Dormant | 31 October | 100% |
Harbourside Leisure Management Company Limited | 1 | Active | 30 December | 71.43% |
Landscape Estates Limited | 1 | Dormant | 31 October | 100% |
Mertonplace Limited | 1 | Dormant | 31 October | 100% |
Nicholson Estates (Century House) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Central Plaza) Limited | 1 | Dormant | 31 October | 100% |
Ellis Mews (Park Central) Management Limited | 1 | Active | 31 October | 100% |
Park Central Management (Zone 11) Limited | 1 | Dormant | 31 October | 100% |
Voting | ||||
rights and | ||||
share- | ||||
holding | ||||
Registered | Active/ | (direct or | ||
Entity name | office 1 | dormant Year end date | indirect) | |
Park Central Management (Zone 12) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 1A North) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 1A South) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 1B) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 3/1) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 3/2) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 3/3) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 3/4) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 4/41 and 42) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 4/43/44) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 5/53) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 5/54) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 5/55) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 6/61-64) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 7/9) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 8) Limited | 1 | Dormant | 31 October | 100% |
Park Central Management (Zone 9/91) Limited | 1 | Dormant | 31 January | 100% |
Park West Management Services Limited | 1 | Active | 29 March | 62.00% |
Voting | ||||
rights and | ||||
share- | ||||
holding | ||||
Registered | Active/ | Year end | (direct or | |
Entity name | office 1 | dormant | date | indirect) |
Material joint ventures | ||||
Crest A2D (Walton Court) LLP | 1 | Active | 31 March | 50% |
Elmsbrook (Crest A2D) LLP | 4 | Active | 31 March | 50% |
Crest Sovereign (Brooklands) LLP | 3 | Active | 31 October | 50% |
Crest Peabody (Turweston) LLP | 1 | Active | 31 March | 50% |
Other joint ventures not material to the Group | ||||
Crest/Vistry (Epsom) LLP | 1 | Active | 31 October | 50% |
Crest Nicholson Bioregional Quintain LLP | 1 | Active | 31 October | 50% |
English Land Banking Company Limited | 1 | Active | 31 October | 50% |
Haydon Development Company Limited | 2 | Active | 30 April | 21.36% |
North Swindon Development Company Limited | 2 | Active 31 December | 32.64% |
As | |||
previously | Represented | As | |
reported | 2023 | presented | |
£m | £m | £m | |
Consolidated income statement | |||
Pre-exceptional | |||
Cost of sales | (556.9) | 5.0 | (551.9) |
Gross profit | 100.6 | 5.0 | 105.6 |
Other operating income | – | 44.7 | 44.7 |
Other operating expenses | – | (40.9) | (40.9) |
Administrative expenses | (55.8) | (2.2) | (58.0) |
Operating profit | 44.2 | 6.6 | 50.8 |
Profit before tax | 41.4 | 6.6 | 48.0 |
Income tax expense | (10.0) | (1.7) | (11.7) |
Profit for the year attributable to equity shareholders | 31.4 | 4.9 | 36.3 |
Basic earnings per share (pence) | 12.3 | 1.9 | 14.2 |
Diluted earnings per share (pence) | 12.2 | 1.9 | 14.1 |
Exceptional items | |||
Cost of sales | (14.3) | (6.6) | (20.9) |
Gross loss | (14.3) | (6.6) | (20.9) |
Operating loss | (14.3) | (6.6) | (20.9) |
Loss before tax | (18.3) | (6.6) | (24.9) |
Income tax credit | 4.8 | 1.7 | 6.5 |
Loss for the year attributable to equity shareholders | (13.5) | (4.9) | (18.4) |
As | |||
previously | Represented | As | |
reported | 2023 | presented | |
£m | £m | £m | |
Total | |||
Cost of sales | (571.2) | (1.6) | (572.8) |
Gross profit/(loss) | 86.3 | (1.6) | 84.7 |
Other operating income | – | 44.7 | 44.7 |
Other operating expenses | – | (40.9) | (40.9) |
Administrative expenses | (55.8) | (2.2) | (58.0) |
Consolidated statement of financial position | |||
2023 current trade and other payables | (337.0) | 8.4 | (328.6) |
2023 current provisions | (85.5) | (8.4) | (93.9) |
2023 non-current trade and other payables | (71.1) | 1.4 | (69.7) |
2023 non-current provisions | (73.8) | (1.4) | (75.2) |
2022 current trade and other payables | (407.1) | 8.2 | (398.9) |
2022 current provisions | (72.2) | (8.2) | (80.4) |
2022 non-current trade and other payables | (41.8) | 1.6 | (40.2) |
2022 non-current provisions | (70.8) | (1.6) | (72.4) |
As | |||
previously | Represented | As | |
reported | 2023 | presented | |
£m | £m | £m | |
Notes to the accounts | |||
Exceptional completed site costs | – | (6.6) | (6.6) |
Total exceptional cost of sales charge | (14.3) | (6.6) | (20.9) |
Total exceptional charge | (18.3) | (6.6) | (24.9) |
Tax credit on exceptional charge | 4.8 | 1.7 | 6.5 |
Total exceptional charge after tax credit | (13.5) | (4.9) | (18.4) |
Current accruals and deferred income | 125.2 | (8.4) | 116.8 |
Non-current accruals and deferred income | 4.1 | (1.4) | 2.7 |
Financial liability accruals | 123.9 | (9.8) | 114.1 |
Carrying value of financial liabilities carrying no interest | 401.4 | (9.8) | 391.6 |
Total carrying value of financial liabilities carrying no interest | 501.4 | (9.8) | 491.6 |
Contractual cashflows of financial liabilities carrying no interest | 408.8 | (9.8) | 399.0 |
Total contractual cashflows of financial liabilities carrying no interest | 521.3 | (9.8) | 511.5 |
Financial liabilities carrying no interest due within 1 year | 333.5 | (8.4) | 325.1 |
Total financial liabilities carrying no interest due within 1 year | 352.0 | (8.4) | 343.6 |
Financial liabilities carrying no interest – repayable 1-2 years | 44.1 | (1.4) | 42.7 |
Total financial liabilities carrying no interest – repayable 1-2 years | 67.2 | (1.4) | 65.8 |
As | |||
previously | As | ||
reported | Represented | presented | |
Alternative performance measures (unaudited) | £m/% | £m/% | £m/% |
Adjusted operating profit | 44.2 | 6.6 | 50.8 |
Return on capital employed | 6.3% | 1.0% | 7.3% |
Pre-exceptional | |||
Gross profit | 100.6 | 5.0 | 105.6 |
Gross profit margin | 15.3% | 0.8% | 16.1% |
Operating profit | 44.2 | 6.6 | 50.8 |
Operating profit margin | 6.7% | 1.0% | 7.7% |
Profit before tax | 41.4 | 6.6 | 48.0 |
Income tax expense | (10.0) | (1.7) | (11.7) |
Profit after tax | 31.4 | 4.9 | 36.3 |
Basic earnings per share (pence) | 12.3 | 1.9 | 14.2 |
Diluted earnings per share (pence) | 12.2 | 1.9 | 14.1 |
Exceptional items | |||
Gross loss | (14.3) | (6.6) | (20.9) |
Gross loss margin | (2.2)% | (1.0)% | (3.2)% |
Operating loss | (14.3) | (6.6) | (20.9) |
Operating loss margin | (2.2)% | (1.0)% | (3.2)% |
Loss before tax | (18.3) | (6.6) | (24.9) |
Income tax credit | 4.8 | 1.7 | 6.5 |
Loss after tax | (13.5) | (4.9) | (18.4) |
Basic loss per share (pence) | (5.3) | (1.9) | (7.2) |
Diluted loss per share (pence) | (5.2) | (1.9) | (7.1) |
As | |||
previously | As | ||
reported | Represented | presented | |
Alternative performance measures (unaudited) | £m/% | £m/% | £m/% |
Total | |||
Gross profit/(loss) | 86.3 | (1.6) | 84.7 |
Gross profit/(loss) margin | 13.1% | (0.2)% | 12.9% |
Historical summary (unaudited) | |||
Gross profit | 100.6 | 5.0 | 105.6 |
Gross profit margin | 15.3% | 0.8% | 16.1% |
Other operating income | – | 44.7 | 44.7 |
Other operating expenses | – | (40.9) | (40.9) |
Administrative expenses | (55.8) | (2.2) | (58.0) |
Operating profit before joint ventures | 44.2 | 6.6 | 50.8 |
Operating profit before joint ventures margin | 6.7% | 1.0% | 7.7% |
Operating profit after joint ventures | 46.9 | 6.6 | 53.5 |
Operating profit after joint ventures margin | 7.1% | 1.0% | 8.1% |
Profit before taxation | 41.4 | 6.6 | 48.0 |
Income tax expense | (10.0) | (1.7) | (11.7) |
Profit after taxation attributable to equity shareholders | 31.4 | 4.9 | 36.3 |
Basic earnings per share (pence) | 12.3 | 1.9 | 14.2 |
Return on average capital employed | 6.3% | 1.0% | 7.3% |
Return on average equity | 3.6% | 0.6% | 4.2% |